TEKLA CAPITAL MANAGEMENT LLC TScan Therapeutics, Inc. Transaction History

TEKLA CAPITAL MANAGEMENT LLC portfolio value:

$610,000
portfolio value

TEKLA CAPITAL MANAGEMENT LLC quarter portfolio value change:

-3.02%
quarter

TScan Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share 0.00% 0 shares -19K $3.05 200K
Q2 2022 share 0.00% 0 shares 69K $3.15 200K
Q1 2022 share 0.00% 0 shares -340K $2.8 200K
Q4 2021 share 0.00% 0 shares -768K $4.83 200K
Q3 2021 share Increase 0.00% 200K shares 1.66M $8.34 200K